do not combine dpp-4 inhibitors with glp-1 receptor agonists recommendation Use of and Why can't DPP-4 (Dipeptidyl Peptidase-4)

The cagrilintide and semaglutide dosing chart often follows this schedule: Weeks 1-4 start with 0.25mg semaglutide + 0.6mg cagrilintide weekly, Weeks 5-8 increase to 0.5mg semaglutide + 1.2mg cagrilintide, Weeks 9-12 use 1.0mg semaglutide + 1.2mg cagrilintide, Weeks 13-16 escalate to 1.7mg semaglutide + 1.8mg cagrilintide, Weeks 17-20 reach maintenance at 2.4mg each, and Weeks 21+ continue maintenance doses

After reconstitution with a sterile diluent, store at 2 to 8 C (36 to 46 F) and use promptly within laboratory protocols

The infusion notes are still there, but so are checkmarks indicating that Magness received a medical examination beyond the L-carnitine experiment

(Lee et al, 2012)